tiprankstipranks
Trending News
More News >
Nulab Inc. (JP:5033)
:5033
Japanese Market
Advertisement

Nulab Inc. (5033) AI Stock Analysis

Compare
0 Followers

Top Page

JP:5033

Nulab Inc.

(5033)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
¥822.00
▲(0.24% Upside)
Nulab Inc. shows strong financial health and an attractive valuation, but the technical indicators suggest bearish momentum. The stock's undervaluation presents an opportunity, but caution is advised due to current market trends.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion.
Profit Margins
High profit margins reflect efficient operations and pricing power, which can sustain profitability even in competitive markets.
Balance Sheet Health
A strong balance sheet with low debt enhances financial stability and flexibility, enabling strategic investments and growth.
Negative Factors
Operating Cash Flow
Decreasing operating cash flow could signal potential cash management issues, impacting the company's ability to fund operations and growth.
Market Sentiment
Persistent bearish sentiment may affect investor confidence and limit access to capital markets, impacting future growth opportunities.
Cash Flow Monitoring
While cash flow is strong, the decrease requires attention to ensure it does not become a trend, potentially affecting liquidity and investment capacity.

Nulab Inc. (5033) vs. iShares MSCI Japan ETF (EWJ)

Nulab Inc. Business Overview & Revenue Model

Company DescriptionNulab Inc. develops solution that promotes team collaboration. The company offers Backlog, a project management tool; Nulab Pass, a tool which strengthens your organization information security and governance; Cacoo, online drawing tool; and Typetalk, a business chat tool. The company was incorporated in 2004 and is headquartered in Fukuoka City, Japan.
How the Company Makes MoneyNulab Inc. generates revenue primarily through a subscription-based model for its software products. Customers pay monthly or annual fees for access to different tiers of service, which provide varying features and capabilities. This model allows Nulab to have a predictable revenue stream as users commit to long-term subscriptions. Key revenue streams include individual and enterprise subscriptions for each of its core products. Additionally, Nulab may engage in partnerships with other technology firms or platforms that enhance its product offerings and expand its user base, further contributing to its overall earnings through increased visibility and market reach.

Nulab Inc. Financial Statement Overview

Summary
Nulab Inc. demonstrates strong financial performance with impressive revenue growth, healthy profit margins, and a robust balance sheet with minimal debt. The cash flow position is strong, although a slight decrease in operating cash flow warrants monitoring.
Income Statement
85
Very Positive
Nulab Inc. demonstrates strong revenue growth with a significant increase from the previous year. The gross profit margin is healthy at approximately 72%, indicating efficient cost management. Net profit margin has improved, reflecting higher profitability. Additionally, the company shows strong EBIT and EBITDA margins, which suggest robust operational performance.
Balance Sheet
78
Positive
The company's balance sheet reflects a very low debt-to-equity ratio, signifying prudent leverage management. Return on equity is strong, indicating efficient use of shareholder funds. The equity ratio is solid, suggesting a strong capital structure with an emphasis on equity financing over debt.
Cash Flow
80
Positive
Nulab Inc. has a strong cash flow position with consistent operating cash flow growth. The free cash flow to net income ratio is favorable, indicating good cash generation relative to reported profits. However, a slight decrease in operating cash flow from the previous year suggests a need for caution.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.18B4.11B3.66B2.71B2.33B1.94B
Gross Profit3.07B2.96B2.64B1.73B1.42B1.09B
EBITDA692.35M753.00M424.12M179.14M266.01M66.69M
Net Income505.40M552.68M308.16M88.42M197.88M-25.53M
Balance Sheet
Total Assets4.35B4.24B3.47B2.61B1.62B1.33B
Cash, Cash Equivalents and Short-Term Investments3.22B3.13B2.48B1.74B1.13B878.98M
Total Debt8.36M2.25M5.25M13.75M58.69M154.21M
Total Liabilities2.37B2.34B2.14B1.65B1.23B1.15B
Stockholders Equity1.98B1.91B1.33B958.63M391.25M182.66M
Cash Flow
Free Cash Flow0.00724.95M694.57M169.40M321.29M153.73M
Operating Cash Flow0.00749.13M811.90M297.32M401.01M242.03M
Investing Cash Flow0.00-128.81M-110.72M-130.74M-74.35M-80.91M
Financing Cash Flow0.00-1.00M16.87M417.41M-95.27M-119.66M

Nulab Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price820.00
Price Trends
50DMA
806.44
Positive
100DMA
843.21
Positive
200DMA
903.20
Negative
Market Momentum
MACD
1.59
Negative
RSI
63.22
Neutral
STOCH
75.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5033, the sentiment is Positive. The current price of 820 is above the 20-day moving average (MA) of 777.45, above the 50-day MA of 806.44, and below the 200-day MA of 903.20, indicating a neutral trend. The MACD of 1.59 indicates Negative momentum. The RSI at 63.22 is Neutral, neither overbought nor oversold. The STOCH value of 75.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5033.

Nulab Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥5.42B12.001.28%13.05%3.18%
78
Outperform
¥4.51B10.151.42%39.66%57.28%
66
Neutral
¥4.91B10.967.60%19.13%
65
Neutral
¥5.28B21.7011.35%160.35%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
¥5.58B26.471.91%10.65%28.85%
58
Neutral
¥4.86B-70.611.91%-122.15%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:5033
Nulab Inc.
856.00
85.00
11.02%
JP:3653
Morpho, Inc.
877.00
-748.00
-46.03%
JP:4372
YMIRLINK,Inc.
1,435.00
81.20
6.00%
JP:4379
Photosynth inc.
331.00
-12.00
-3.50%
JP:4428
Sinops, Inc.
801.00
65.55
8.91%
JP:4440
WITZ Corp.
1,043.00
192.22
22.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025